The abstract is read at the publisher; the summary is JClub's.
Longitudinal RB1 ctDNA VAF in plasma is linked to extraocular retinoblastoma in 4/33 intraocular patients, with rising plasma VAF marking those who developed spread.
- Why it matters: Extraocular disease and CNS relapse drive outcomes in retinoblastoma, but reliable, minimally invasive markers for risk and monitoring are limited.
- What they did: MSKCC and SCEH records were reviewed for serial plasma and CSF ctDNA in retinoblastoma patients, tracking RB1 ctDNA detectability and variant allele frequency over time.
- The result: RB1 ctDNA stayed undetectable in 29 patients without extraocular disease; in CNS disease, CSF ctDNA was positive in all 7 at diagnosis and rising levels at relapse were associated with death or recurrence.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.